Washington DC Sunrise

 

 

Recent Advocacy

  • AIPLA Comments on Joint USPTO-FDA Collaboration Initiatives

    February 28, 2023

    Arlington, VA. February 28, 2023 - The American Intellectual Property Law Association (AIPLA) submitted comments to the United States Patent and Trademark Office (USPTO) in response to the USPTO’s Request for Comments on Joint USPTO-FDA Collaboration Initiatives.
  • AIPLA Comments on USPTO Initiatives to Ensure the Robustness and Reliability of Patent Rights

    February 8, 2023

    Arlington, VA. February 8, 2023 - The American Intellectual Property Law Association (AIPLA) submitted comments to the United States Patent and Trademark Office’s ("The Office”) Request for Comments on possible initiatives of the Office to ensure the robustness and reliability of patent rights.
  • AIPLA Comments on Joint Study on Non-Fungible Tokens (NFTs) and Intellectual Property

    February 8, 2023

    Arlington, VA. February 8, 2023 - The American Intellectual Property Law Association (AIPLA) submitted comments to the United States Patent and Trademark Office and the United States Copyright Office in response to their joint study on the issues of intellectual property law and policy associated with non-fungible tokens (NFTs).